General Archive
-
Articles & blogs
Covid-19 hub shortlisted for Scottish award
Unique translational research hub for Covid-19 and other viruses was a finalist in the Scottish Knowledge Exchange Awards.
-
Articles & blogs
Living with genetic sight loss – a family story
Late-onset retinal degeneration (L-ORD) is a rare inherited eye disease that leads to blindness in older people.
-
Articles & blogs
Can an innovative gene therapy help people with Hunter syndrome?
Danny was diagnosed with Hunter syndrome when he was three years old.
-
Articles & blogs
Living with a rare but incurable liver disease
A young actor had to battle a rare liver disease before he could start out on his career.
-
Articles & blogs
LifeArc – advancing innovation in rare disease
We act as a trusted partner to transform the way rare diseases are identified and treated.
-
Articles & blogs
Celebrating our inspirational women scientists
Today is the UN’s International Day of Women and Girls in Science and we are delighted to have so many inspiring…
-
Articles & blogs
Reflecting on 2021 – a year of progress
As we bid farewell to another challenging year, we reflect on our work with partners and colleagues in 2021.
-
Articles & blogs
LifeArc scientist wins prestigious Industrial Fellowship
LifeArc scientist receives an industry fellowship from the Royal Commission for the Exhibition of 1851
-
Articles & blogs
A warm welcome to our 2021-2 industrial placement students
Welcoming students to our industrial placement scheme for 2021
-
Articles & blogs
Highlights of the year from our outgoing placement students
Students from our industrial placement scheme for 2020 review their year working in drug discovery at LifeArc
-
Articles & blogs
Industrialising academic-led gene therapies
Sven Kili, Chair of the Coordinating Committee overseeing the creation of the Gene Therapy Innovation Hubs, discusses how Gene Therapy…
-
Articles & blogs
Kickstart drug repurposing: smashing the roadblocks on the route to patients
How LifeArc aims to support charities, researchers and funders exploring new uses for existing medicines